The effect of captopril on cutaneous blood flow in patients with primary Raynaud's phenomenon

summary Fifteen patients with primary Raynaud's phenomenon received captopril 25 mg or placebo, three times daily for 6 weeks, in a randomized double‐blind cross‐over study. Compared with placebo, captopril produced a significant improvement in cutaneous blood flow but did not alter the frequen...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of dermatology (1951) 1987-12, Vol.117 (6), p.751-758
Hauptverfasser:	RUSTIN, M.H.A., ALMOND, N.E., BEACHAM, J.A., BROOKS, R.J., JONES, D.P., COOKE, E.D., Dowd, P.M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Biological and medical sciences Captopril - pharmacology Captopril - therapeutic use Clinical Trials as Topic Double-Blind Method Female Humans Medical sciences Middle Aged Pharmacology. Drug treatments Random Allocation Raynaud Disease - drug therapy Raynaud Disease - physiopathology Regional Blood Flow - drug effects Skin - blood supply Skin, nail, hair, dermoskeleton
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	summary Fifteen patients with primary Raynaud's phenomenon received captopril 25 mg or placebo, three times daily for 6 weeks, in a randomized double‐blind cross‐over study. Compared with placebo, captopril produced a significant improvement in cutaneous blood flow but did not alter the frequency or severity of attacks of Raynaud's phenomenon.
ISSN:	0007-0963 1365-2133
DOI:	10.1111/j.1365-2133.1987.tb07356.x